EU Expects Answers from AstraZeneca
Following AstraZeneca‘s announcement that it will be delivering less vaccine than planned, Brussels is threatening legal action. In the responsible committee of the EU Commission, the manufacturer should now provide answers to pressing questions.
The EU and its member states have provided the pharmaceutical industry with around one billion euros to develop a corona vaccine. But when it comes to vaccination, countries that do not belong to the European Union are ahead. Israel, for example. The USA. And the direct EU neighbor Great Britain.
In the United Kingdom alone, more people had been vaccinated in the last three days than in France during the entire corona pandemic, British Health Minister Matt Hancock polemicized. And he pretends to have a vaccination available at the beginning of the pandemic. What is certain, however, is that three quarters of people over 80 in Great Britain have already been vaccinated.
No EU member state has succeeded in doing this so far. However, the UK also benefits from the extradition policy of the British-Swedish group AstraZeneca. Has been supplying Great Britain with the corona vaccine without any restrictions since the beginning of December. It is still not approved in the EU. By Friday at the latest, the European Medicines Agency (EMA) will decide whether to give the green light.
But even if it does so this week, AstraZeneca will deliver around 60 percent less vaccine to the EU than contractually promised last year. “The fact that the UK continues to deliver as planned and that the European Union is cutting back,” says European politician and vaccine expert Peter Liese as a provocation.
EU Expects Answers from AstraZeneca - /10